关注
Nagaraj Chandran
Nagaraj Chandran
Ludwig Boltzmann Institute for Lung Vascular Research
在 lvr.lbg.ac.at 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
D Zabini, A Heinemann, V Foris, C Nagaraj, P Nierlich, Z Bálint, ...
European Respiratory Journal 44 (4), 951-962, 2014
1202014
Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries
C Nagaraj, B Tang, Z Bálint, M Wygrecka, A Hrzenjak, G Kwapiszewska, ...
European Respiratory Journal 41 (1), 85-95, 2013
1152013
Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells
B Tang, Y Li, C Nagaraj, RE Morty, S Gabor, E Stacher, R Voswinckel, ...
American journal of respiratory cell and molecular biology 41 (4), 476-483, 2009
832009
Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension
R Papp, C Nagaraj, D Zabini, BM Nagy, M Lengyel, DS Maurer, N Sharma, ...
European Respiratory Journal 53 (6), 2019
782019
Ion channels in pulmonary hypertension: a therapeutic interest?
M Lambert, V Capuano, A Olschewski, J Sabourin, C Nagaraj, B Girerd, ...
International journal of molecular sciences 19 (10), 3162, 2018
772018
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications
A Olschewski, EL Veale, BM Nagy, C Nagaraj, G Kwapiszewska, ...
European Respiratory Journal 50 (5), 2017
722017
Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction
D Zabini, C Nagaraj, E Stacher, IM Lang, P Nierlich, W Klepetko, ...
Public Library of Science 7 (8), e43793, 2012
702012
Peroxisome proliferator–activated receptor–β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation
Y Li, M Connolly, C Nagaraj, B Tang, Z Bálint, H Popper, ...
American journal of respiratory cell and molecular biology 46 (3), 372-379, 2012
572012
TASK-1 regulates apoptosis and proliferation in a subset of non-small cell lung cancers
K Leithner, B Hirschmugl, Y Li, B Tang, R Papp, C Nagaraj, E Stacher, ...
PloS one 11 (6), e0157453, 2016
482016
Importance of kynurenine in pulmonary hypertension
BM Nagy, C Nagaraj, A Meinitzer, N Sharma, R Papp, V Foris, B Ghanim, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 313 (5 …, 2017
462017
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
PP Jain, R Leber, C Nagaraj, G Leitinger, B Lehofer, H Olschewski, ...
International journal of nanomedicine, 3249-3261, 2014
462014
STIM1/ORAI1-mediated Ca2+ influx regulates enolase-1 exteriorization
M Didiasova, D Zakrzewicz, V Magdolen, C Nagaraj, Z Bálint, M Rohde, ...
Journal of Biological Chemistry 290 (19), 11983-11999, 2015
432015
Ion channels and transporters as therapeutic targets in the pulmonary circulation
A Olschewski, R Papp, C Nagaraj, H Olschewski
Pharmacology & therapeutics 144 (3), 349-368, 2014
412014
Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension
C Nagaraj, B Tang, BM Nagy, R Papp, PP Jain, LM Marsh, AL Meredith, ...
European Respiratory Journal 48 (4), 1127-1136, 2016
322016
Nano-and micropatterned polycaprolactone cellulose composite surfaces with tunable protein adsorption, fibrin clot formation, and endothelial cellular response
T Mohan, C Nagaraj, BM Nagy, M Bračič, U Maver, A Olschewski, ...
Biomacromolecules 20 (6), 2327-2337, 2019
312019
Interaction of tissue engineering substrates with serum proteins and its influence on human primary endothelial cells
T Mohan, K Niegelhell, C Nagaraj, D Reishofer, S Spirk, A Olschewski, ...
Biomacromolecules 18 (2), 413-421, 2017
282017
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
H Le Ribeuz, L To, MR Ghigna, C Martin, C Nagaraj, E Dreano, ...
European Respiratory Journal 58 (5), 2021
262021
Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox
C Nagaraj, C Tabeling, BM Nagy, PP Jain, LM Marsh, R Papp, M Pienn, ...
European Respiratory Journal 50 (1), 2017
262017
Rho-kinase inhibition ameliorates dasatinib-induced endothelial dysfunction and pulmonary hypertension
C Fazakas, C Nagaraj, D Zabini, AG Végh, LM Marsh, I Wilhelm, ...
Frontiers in Physiology 9, 537, 2018
252018
Endothelial dysfunction following enhanced TMEM16A activity in human pulmonary arteries
D Skofic Maurer, D Zabini, C Nagaraj, N Sharma, M Lengyel, BM Nagy, ...
Cells 9 (9), 1984, 2020
232020
系统目前无法执行此操作,请稍后再试。
文章 1–20